Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
CRISPR Therapeutics AG - Common Shares
(NQ:
CRSP
)
48.87
-1.06 (-2.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about CRISPR Therapeutics AG - Common Shares
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
35
36
Next >
Could This Stock Become the Tesla of Its Industry?
↗
March 25, 2023
It's in a race to a multi-billion dollar market.
Via
The Motley Fool
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
↗
March 25, 2023
Moving forward, CRISPR could revolutionize the way we treat thousands of diseases. The best CRISPR stocks will profit from it.
Via
InvestorPlace
3 Simple Ways to Supercharge Your Biopharma Investing Using Artificial Intelligence
↗
March 24, 2023
Your stock screening and research process will never be the same.
Via
The Motley Fool
This Cathie Wood Stock Could Nearly Double, According to Wall Street
↗
March 23, 2023
If the stock market continues to rally, this biotech could benefit.
Via
The Motley Fool
Thinking of Buying Biotech Stocks? Do These 3 Things First
↗
March 22, 2023
It's better to plan ahead than to get caught by surprise.
Via
The Motley Fool
Expert Ratings for CRISPR Therapeutics
↗
March 21, 2023
Via
Benzinga
Expert Ratings for CRISPR Therapeutics
↗
February 27, 2023
Via
Benzinga
Looking Into CRISPR Therapeutics's Return On Invested Capital
↗
February 22, 2023
Via
Benzinga
Beat the Dow Jones With CRISPR Therapeutics Stock
↗
February 17, 2023
If approved, CRISPR's first product may deliver blockbuster sales.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
↗
March 21, 2023
Via
Benzinga
3 Cutting-Edge Healthcare Stocks That Can Pay Off Big Time
↗
March 18, 2023
For investors betting on healthcare, look for these three companies to provide the treatments of tomorrow.
Via
InvestorPlace
3 Beaten-Down Stocks That Could Soar This Year
↗
March 18, 2023
These stocks could enjoy big rebounds in 2023.
Via
The Motley Fool
2 Top Biotech Stocks to Buy for the Long Haul
↗
March 15, 2023
These companies have what it takes to grow their revenues -- and their share prices -- over time.
Via
The Motley Fool
If You Invested $10,000 in CRISPR Therapeutics In 2020, This Is How Much You Would Have Today
↗
March 10, 2023
The stock has been on a wild ride over the past few years.
Via
The Motley Fool
Missed Out on Vertex? My Best Gene-Editing Stock to Buy and Hold
↗
March 09, 2023
Get in on CRISPR Therapeutics before it gets expensive.
Via
The Motley Fool
2 Healthcare Stocks That Could Help Make You a Fortune
↗
March 08, 2023
These companies also happen to be a bargain right now.
Via
The Motley Fool
7 Cathie Wood Stocks for Your March Buy List
↗
March 07, 2023
These top Cathie Wood stocks are just now attempting to pivot higher after a miserable outing for much of 2022.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For March 7, 2023
↗
March 07, 2023
Via
Benzinga
3 CRISPR Gene Editing Stocks to Consider for Ground-Floor Investing
↗
March 06, 2023
CRISPR Therapeutics, Beam Therapeutics and Vertex Pharmaceuticals are three CRISPR gene editing stocks you won't want to miss out on.
Via
InvestorPlace
Better Growth Stock: Moderna vs. CRISPR Therapeutics
↗
March 05, 2023
Both stocks are ripe for a rebound.
Via
The Motley Fool
3 Things About CRISPR Therapeutics That Smart Investors Know
↗
March 04, 2023
Institutional investors might be on to something.
Via
The Motley Fool
3 Game-Changing Stocks to Buy in March
↗
March 04, 2023
Innovation is in these companies' DNA.
Via
The Motley Fool
2 Soaring Stocks to Buy and Hold Through 2023 and Beyond
↗
March 03, 2023
Investors are bidding up shares of these companies, and there are good reasons for doing so.
Via
The Motley Fool
10 Best Stocks to Buy in March 2023
↗
March 01, 2023
These diversified growth stocks could add rocket fuel to your long-term investment portfolio.
Via
The Motley Fool
Here's How Much You Can Make From Investing Your Tax Return Every Year
↗
February 27, 2023
Doing this can strengthen your retirement plan.
Via
The Motley Fool
Better Buy: Beam Therapeutics or Intellia Therapeutics?
↗
February 22, 2023
The two clinical-stage gene-editing companies have good long-term prospects.
Via
The Motley Fool
2 Bruised Growth Stocks to Buy While They're Cheap
↗
February 21, 2023
Both are on the verge of fast growth, and they haven't had any major setbacks yet.
Via
The Motley Fool
SMID Cap Life Science Update: Are You An Investor Or Trader?
↗
February 20, 2023
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.
Via
Talk Markets
2 Marvelous Growth Stocks to Buy Today and Hold for 5 Years or Longer
↗
February 18, 2023
These two companies are on track to flourish through the end of the decade.
Via
The Motley Fool
These 2 Biotech Stocks Could Soar in the Next Bull Market
↗
February 17, 2023
They're both at the cutting edge of gene-editing technology.
Via
The Motley Fool
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
35
36
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
